Medical News

RSS

iPierian raises $28 million from Series B equity financing closure

iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the second closing of its Series B equity financing, bringing the total amount raised in this round to $28 million.

9 Sep 2010

Eating Disorder Hope poise growth from Timberline Knolls sponsorship to educate sufferers

Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, is poised for growth following a significant sponsorship commitment by Timberline Knolls Residential Treatment Center.

9 Sep 2010

Spirus Medical obtains Japanese marketing approval for ENDO-EASE line of endoscopy devices

Spirus Medical announced today that it has obtained marketing approval from the Japanese Ministry of Health, Labor and Welfare for the company's proprietary ENDO-EASE line of endoscopy devices. The Endo-Ease Endoluminal Advancement System features novel "over-tubes" that use a spiral design utilizing simple rotation to facilitate enteroscopy, colonoscopy and ileoscopy.

9 Sep 2010

Federal judge refuses to lift order blocking federal funding for stem cell research

The Associated Press: "A federal judge on Tuesday refused to lift his order blocking federal funding for some stem cell research, saying that a 'parade of horribles' predicted by federal officials would not happen. Medical researchers value stem cells because they are master cells that can turn into any tissue of the body.

9 Sep 2010

AERI merges with AHEADD to support communities impacted by Autism Spectrum Disorder

The Autism Education and Research Institute (AERI), an organization committed to providing consultative services that incorporates innovative current research in the field of autism, announces their merging with Achieving in Higher Education with Autism / Developmental Disabilities (AHEADD) in order to support consumers, families, schools, and their surrounding communities who are impacted by Autism Spectrum Disorders (ASD).

9 Sep 2010

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

High testosterone levels in CEOs negotiating mergers and acquisitions are linked to a higher rate of dropped deals and an increase in hostile takeover attempts, according to a new study in the current issue of Management Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS-).

9 Sep 2010

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Using a newly FDA approved pulmonary valve, Dr. Frank Ing, director of the catheterization laboratory at Texas Children's Hospital and his team of pediatric interventional cardiologists implanted a transcatheter pulmonary heart valve into the heart of a 13-year-old girl, which spared her from having her chest opened for a third heart surgery.

9 Sep 2010

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

EDAP TMS SA, the global leader in therapeutic ultrasound, today reported favorable clinical outcomes for patients treated with Ablatherm-HIFU.

9 Sep 2010

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Nevirapine is widely used to help prevent mother-to-child transmission of the HIV virus. In cases where the infants are nonetheless infected with HIV virus at birth, the standard treatment is to use protease inhibitors (PI) to reduce the amount of virus in their bloodstream. A new study involving 195 infants in South Africa found that children who were treated with PI and then switched to nevirapine were more likely to maintain virus below the detection threshold of the test than infants who continued to receive PI.

9 Sep 2010

Irregular body weight increases mortality risk in women with colon cancer: Study

Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

9 Sep 2010

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).

9 Sep 2010

CVS Caremark offers $5 million in free flu shots for uninsured patients

CVS Caremark announced today that it will partner with Direct Relief USA to offer up to $5 million in free flu shots to community clinic and health center patients who lack health insurance.

9 Sep 2010

Insurers raise rates, cancel plans in response to overhaul

The Wall Street Journal: "Aetna Inc., some BlueCross BlueShield plans and other smaller carriers have asked for premium increases of between 1% and 9% to pay for extra benefits required under the law, according to filings with state regulators." The requests undermine "Democrats' efforts to trumpet their signature achievement before the midterm elections."

9 Sep 2010

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.

9 Sep 2010

Researchers report massage improves body’s immune response

Researchers in Cedars-Sinai's Department of Psychiatry and Behavioral Neurosciences have reported people who undergo massage experience measureable changes in their body's immune and endocrine response.

9 Sep 2010

$GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL$

GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL

GlaxoSmithKline and Genmab A/S announced today the start of a Phase III study in patients with indolent B-cell non-Hodgkin's lymphoma (B-NHL) who did not respond to or progressed during, or within 6 months of a rituximab containing regimen.

9 Sep 2010

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.

9 Sep 2010

Health reform myths debunked

The Associated Press examines political ads on health reform. "With the country sharply divided over the sweeping new insurance law, Republicans and their allies are taking to the airwaves to attack it as elections near, often resorting to exaggeration and omissions to make their points."

9 Sep 2010

BioSpace joins Delaware BioScience to launch online career center for life science markets

BioSpace has partnered with the Delaware BioScience Association to launch an online career center for life science markets including pharmaceuticals and biotechnology.

9 Sep 2010

Helicos accuses PacBio of patent infringement, files lawsuit

Helicos BioSciences Corporation announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.

9 Sep 2010

Medical News

iPierian raises $28 million from Series B equity financing closure

Eating Disorder Hope poise growth from Timberline Knolls sponsorship to educate sufferers

Spirus Medical obtains Japanese marketing approval for ENDO-EASE line of endoscopy devices

Federal judge refuses to lift order blocking federal funding for stem cell research

AERI merges with AHEADD to support communities impacted by Autism Spectrum Disorder

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Irregular body weight increases mortality risk in women with colon cancer: Study

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

CVS Caremark offers $5 million in free flu shots for uninsured patients

Insurers raise rates, cancel plans in response to overhaul

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers report massage improves body’s immune response

GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Health reform myths debunked

BioSpace joins Delaware BioScience to launch online career center for life science markets

Helicos accuses PacBio of patent infringement, files lawsuit

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News